Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
10 Jul 2020
Historique:
received: 02 06 2020
revised: 03 07 2020
accepted: 07 07 2020
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 26 2 2021
Statut: epublish

Résumé

The noteworthy intensification in the development of nanotechnology has led to the development of various types of nanoparticles. The diverse applications of these nanoparticles make them desirable candidate for areas such as drug delivery, coasmetics, medicine, electronics, and contrast agents for magnetic resonance imaging (MRI) and so on. Iron oxide magnetic nanoparticles are a branch of nanoparticles which is specifically being considered as a contrast agent for MRI as well as targeted drug delivery vehicles, angiogenic therapy and chemotherapy as small size gives them advantage to travel intravascular or intracavity actively for drug delivery. Besides the mentioned advantages, the toxicity of the iron oxide magnetic nanoparticles is still less explored. For in vivo applications magnetic nanoparticles should be nontoxic and compatible with the body fluids. These particles tend to degrade in the body hence there is a need to understand the toxicity of the particles as whole and degraded products interacting within the body. Some nanoparticles have demonstrated toxic effects such inflammation, ulceration, and decreases in growth rate, decline in viability and triggering of neurobehavioral alterations in plants and cell lines as well as in animal models. The cause of nanoparticles' toxicity is attributed to their specific characteristics of great surface to volume ratio, chemical composition, size, and dosage, retention in body, immunogenicity, organ specific toxicity, breakdown and elimination from the body. In the current review paper, we aim to sum up the current knowledge on the toxic effects of different magnetic nanoparticles on cell lines, marine organisms and rodents. We believe that the comprehensive data can provide significant study parameters and recent developments in the field. Thereafter, collecting profound knowledge on the background of the subject matter, will contribute to drive research in this field in a new sustainable direction.

Identifiants

pubmed: 32664325
pii: molecules25143159
doi: 10.3390/molecules25143159
pmc: PMC7397295
pii:
doi:

Substances chimiques

Ferric Compounds 0
Magnetite Nanoparticles 0
ferric oxide 1K09F3G675

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

NMR Biomed. 2004 Nov;17(7):484-99
pubmed: 15526347
J Nanobiotechnology. 2015 Feb 26;13:16
pubmed: 25880445
Mol Imaging Biol. 2011 Jun;13(3):443-451
pubmed: 20567925
Toxicol Appl Pharmacol. 2011 Jun 1;253(2):81-93
pubmed: 21435349
Chem Rev. 2012 Nov 14;112(11):5818-78
pubmed: 23043508
Chemosphere. 2020 May;247:125900
pubmed: 31951957
Drug Chem Toxicol. 2019 Jan;42(1):1-8
pubmed: 29281933
Sci Rep. 2018 Feb 1;8(1):2082
pubmed: 29391477
Biomaterials. 2005 Jun;26(18):3995-4021
pubmed: 15626447
Annu Rev Chem Biomol Eng. 2010;1:149-73
pubmed: 22432577
J Biomed Mater Res A. 2007 Feb;80(2):333-41
pubmed: 17001648
Biomaterials. 2009 Dec;30(36):6803-13
pubmed: 19765821
Curr Opin Biotechnol. 2007 Dec;18(6):565-71
pubmed: 18160274
Biomaterials. 2015 Jan;39:67-74
pubmed: 25477173
Colloids Surf B Biointerfaces. 2010 Jan 1;75(1):1-18
pubmed: 19782542
Int J Nanomedicine. 2010 Nov 16;5:983-9
pubmed: 21187917
Angew Chem Int Ed Engl. 2007;46(8):1222-44
pubmed: 17278160
Chem Soc Rev. 2012 Jun 7;41(11):4306-34
pubmed: 22481569
Dalton Trans. 2015 May 21;44(19):9140-8
pubmed: 25901793
Biochim Biophys Acta Gen Subj. 2017 Jun;1861(6):1597-1605
pubmed: 28161480
J Nanosci Nanotechnol. 2006 Nov;6(11):3517-20
pubmed: 17252802
Adv Drug Deliv Rev. 2009 Jun 21;61(6):467-77
pubmed: 19389434
J Control Release. 2013 Oct 28;171(2):225-33
pubmed: 23906866
Occup Environ Med. 2004 Sep;61(9):727-8
pubmed: 15317911
Arch Toxicol. 2012 May;86(5):685-700
pubmed: 22076106
Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110652
pubmed: 32228923
N Engl J Med. 2003 Jun 19;348(25):2491-9
pubmed: 12815134
Int J Nanomedicine. 2018 Mar 12;13:1471-1482
pubmed: 29559776
Nanomaterials (Basel). 2019 Mar 18;9(3):
pubmed: 30889833
Sci Total Environ. 2014 Jun 15;484:176-84
pubmed: 24705300
Chem Rev. 2012 Apr 11;112(4):2323-38
pubmed: 22216932
Int J Pharm. 2008 Dec 8;364(2):298-327
pubmed: 18621492
Science. 2006 Feb 3;311(5761):622-7
pubmed: 16456071
Nanoscale Res Lett. 2008 Oct 02;3(11):397-415
pubmed: 21749733
J Am Chem Soc. 2002 Jul 17;124(28):8204-5
pubmed: 12105897
Small. 2008 Jan;4(1):26-49
pubmed: 18165959
Colloids Surf B Biointerfaces. 2019 May 1;177:253-259
pubmed: 30763790
Bioorg Chem. 2018 Feb;76:501-509
pubmed: 29310081
Mayo Clin Proc. 2014 Mar;89(3):382-93
pubmed: 24582196
Anal Chim Acta. 2010 Aug 3;674(2):157-65
pubmed: 20678625
Nanoscale. 2018 Jan 3;10(2):690-704
pubmed: 29242877
Am J Nephrol. 2007;27(6):572-9
pubmed: 17804904
Toxicol Appl Pharmacol. 2009 Jan 15;234(2):222-35
pubmed: 18983864
Small. 2013 May 27;9(9-10):1533-45
pubmed: 23019129
Magn Reson Med. 2010 Apr;63(4):1031-43
pubmed: 20373404
Int J Nanomedicine. 2011;6:1793-800
pubmed: 21980242
Nat Nanotechnol. 2008 Mar;3(3):145-50
pubmed: 18654486
J Nanobiotechnology. 2016 May 14;14(1):37
pubmed: 27179923
Nanotoxicology. 2015 May;9 Suppl 1:95-105
pubmed: 23763576
Int J Nanomedicine. 2008;3(2):169-80
pubmed: 18686777
Adv Exp Med Biol. 2018;1048:311-322
pubmed: 29453546
Molecules. 2020 May 11;25(9):
pubmed: 32403340
Sci Rep. 2015 Nov 05;5:16209
pubmed: 26537855
Front Chem. 2014 Jul 15;2:48
pubmed: 25077142
Nanoscale Res Lett. 2012 Feb 21;7(1):144
pubmed: 22348683
Int J Mol Sci. 2015 Dec 18;16(12):30251-68
pubmed: 26694381
Biomaterials. 2011 Sep;32(26):6291-301
pubmed: 21684593
Int J Pharm. 2015 Jul 25;490(1-2):190-9
pubmed: 25997662
ACS Nano. 2009 Aug 25;3(8):2129-38
pubmed: 19621879
J Trace Elem Med Biol. 2016 Dec;38:53-63
pubmed: 27056797
Environ Sci Technol. 2011 Mar 15;45(6):2172-8
pubmed: 21341780
J Occup Health. 2008;50(1):1-6
pubmed: 18285638
Contrast Media Mol Imaging. 2011 May-Jun;6(3):153-64
pubmed: 21698773
Nanomedicine (Lond). 2015 Feb;10(3):375-86
pubmed: 25407827
PLoS One. 2012;7(1):e29997
pubmed: 22253854
Artif Cells Nanomed Biotechnol. 2016;44(2):722-34
pubmed: 25435409
3 Biotech. 2018 Jun;8(6):279
pubmed: 29881657
J Pharmacol Exp Ther. 2006 Jul;318(1):108-16
pubmed: 16608917
Mol Pharm. 2008 Mar-Apr;5(2):316-27
pubmed: 18217714
Nanotechnology. 2016 Aug 12;27(32):324002
pubmed: 27354334
J Biomed Mater Res A. 2011 Jan;96(1):186-95
pubmed: 21105167
Bioresour Technol. 2018 Dec;269:121-126
pubmed: 30157443
Nanomedicine. 2017 Feb;13(2):559-568
pubmed: 27558352
Biomaterials. 2007 Mar;28(9):1629-42
pubmed: 17178155
Magn Reson Med. 2015 Jan;73(1):376-89
pubmed: 24753150
Expert Rev Hematol. 2018 Oct;11(10):829-834
pubmed: 30188740
Biomaterials. 2017 Jan;114:62-70
pubmed: 27846403
Aquat Toxicol. 2016 Mar;172:9-20
pubmed: 26751245
World J Gastroenterol. 2015 Dec 21;21(47):13400-2
pubmed: 26715826
Anal Chem. 2003 Dec 15;75(24):6843-52
pubmed: 14670044
Annu Rev Anal Chem (Palo Alto Calif). 2013;6:53-81
pubmed: 23451718
Toxicol Rep. 2014 Nov 07;2:27-39
pubmed: 28962334
Mol Pharm. 2009 Sep-Oct;6(5):1417-28
pubmed: 19445482
Nanotechnology. 2009 Mar 18;20(11):115103
pubmed: 19420433
AJNR Am J Neuroradiol. 2017 Jul;38(7):1297-1302
pubmed: 28495944
Environ Pollut. 2012 Mar;162:216-22
pubmed: 22243867
Environ Technol. 2009 May;30(6):583-609
pubmed: 19603705
Immunity. 2016 Sep 20;45(3):583-596
pubmed: 27566941
Nanotoxicology. 2015 May;9 Suppl 1:66-78
pubmed: 23927440
Environ Health Perspect. 2005 Jul;113(7):823-39
pubmed: 16002369
Swiss Med Wkly. 2010 Sep 17;140:w13081
pubmed: 20853192
Eur J Pharm Biopharm. 2008 Jan;68(1):129-37
pubmed: 17881203
Radiology. 2003 Dec;229(3):838-46
pubmed: 14657318
Bioeng Transl Med. 2019 Sep 05;4(3):e10143
pubmed: 31572799
Int J Nanomedicine. 2011;6:1229-35
pubmed: 21753874
Biomaterials. 2002 Apr;23(7):1553-61
pubmed: 11922461
Front Pharmacol. 2017 Mar 28;8:154
pubmed: 28400730
J Nanosci Nanotechnol. 2007 Aug;7(8):2933-7
pubmed: 17685322
Langmuir. 2008 Jun 3;24(11):5787-94
pubmed: 18454562
Chem Rec. 2016 Feb;16(1):458-72
pubmed: 26805951
J Colloid Interface Sci. 2009 Aug 15;336(2):510-8
pubmed: 19476952
Biotech Histochem. 2016;91(1):48-62
pubmed: 26555774
J Biomed Mater Res A. 2006 Sep 1;78(3):550-7
pubmed: 16736484
Nanomedicine (Lond). 2007 Feb;2(1):23-39
pubmed: 17716188
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nanomaterials (Basel). 2019 Jun 09;9(6):
pubmed: 31181856
Nanomedicine (Lond). 2006 Aug;1(2):157-68
pubmed: 17716105
Aquat Toxicol. 2015 Sep;166:21-8
pubmed: 26197244
ScientificWorldJournal. 2014;2014:754721
pubmed: 25197711
Trends Biotechnol. 2011 Jul;29(7):323-32
pubmed: 21489647
Toxicol Appl Pharmacol. 2008 Sep 1;231(2):208-15
pubmed: 18519141
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13549-54
pubmed: 14597719
Neurotoxicology. 2020 Mar;77:80-93
pubmed: 31899250
Theranostics. 2018 May 11;8(12):3284-3307
pubmed: 29930730

Auteurs

Nemi Malhotra (N)

Department of Biomedical Engineering, Chung Yuan Christian University, Chung-Li 32023, Taiwan.

Jiann-Shing Lee (JS)

Department of Applied Physics, National Pingtung University, Pingtung 90007, Taiwan.

Rhenz Alfred D Liman (RAD)

The Graduate School, University of Santo Tomas, Manila 1015, Philippines.

Johnsy Margotte S Ruallo (JMS)

The Graduate School, University of Santo Tomas, Manila 1015, Philippines.

Oliver B Villaflores (OB)

Department of Biochemistry, Faculty of Pharmacy and Research Center for Natural and Applied Sciences, University of Santo Tomas, Manila 1015, Philippines.

Tzong-Rong Ger (TR)

Department of Biomedical Engineering, Chung Yuan Christian University, Chung-Li 32023, Taiwan.

Chung-Der Hsiao (CD)

Department of Bioscience Technology, Chung Yuan Christian University, Chung-Li 32023, Taiwan.
Department of Chemistry, Chung Yuan Christian University, Chung-Li 32023, Taiwan.
Center for Nanotechnology, Chung Yuan Christian University, Chung-Li 32023, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH